Interactive Financial Charts Not Available

OneSource Specialty (ONESOURCE) | Financial Analysis & Statements

OneSource Specialty Pharma Inc. | Large-cap | Healthcare

₹1,861.80

-1.16%

OneSource Specialty vs Biocon OneSource Specialty vs Concord Biotech OneSource Specialty vs Blue Jet Healthcare OneSource Specialty vs Supriya Lifescience OneSource Specialty vs Dishman Carbogen OneSource Specialty vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 3.3B

Gross Profit 2.3B 71.61%

Operating Income 206.8M 6.32%

Net Income -1.9M -0.06%

EPS (Diluted) ₹-0.02

Balance Sheet Metrics

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

OneSource Specialty Income Statement From 2023 to 2025

Metric	2025	2024	2023
Revenue i	14.4B	1.7B	387.1M
Cost of Goods Sold i	4.4B	705.1M	204.1M
Gross Profit i	10.1B	1.0B	183.0M
Gross Margin % i	69.9%	59.0%	47.3%
Operating Expenses
Research & Development i	-	-	-
Selling, General & Administrative i	-	228.7M	327.6M
Other Operating Expenses i	3.3B	1.1B	583.9M
Total Operating Expenses i	3.3B	1.3B	911.5M
Operating Income i	1.9B	-1.6B	-2.2B
Operating Margin % i	13.3%	-95.7%	-557.6%
Non-Operating Items
Interest Income i	-	19.2M	15.8M
Interest Expense i	1.7B	894.5M	401.1M
Other Non-Operating Income	-	-	-
Pre-tax Income i	-670.7M	-3.7B	-4.2B
Income Tax i	-497.8M	0	0
Effective Tax Rate % i	0.0%	0.0%	0.0%
Net Income i	-179.7M	-3.9B	-8.0B
Net Margin % i	-1.2%	-227.5%	-2,066.0%
Key Metrics
EBITDA i	4.8B	-649.3M	-1.2B
EPS (Basic) i	₹-1.63	₹-94.15	₹-192.51
EPS (Diluted) i	₹-1.63	₹-94.15	₹-192.51
Basic Shares Outstanding i	110251534	41546999	41546999
Diluted Shares Outstanding i	110251534	41546999	41546999

Income Statement Trend

OneSource Specialty Balance Sheet From 2023 to 2025

Metric	2025	2024	2023
Assets
Current Assets
Cash & Equivalents i	1.6B	64.7M	49.7M
Short-term Investments i	1.8B	157.9M	45.0M
Accounts Receivable i	4.2B	552.4M	38.2M
Inventory i	1.6B	112.3M	1.3B
Other Current Assets	1.7B	-	-
Total Current Assets i	10.9B	1.8B	2.3B
Non-Current Assets
Property, Plant & Equipment i	9.0B	0	0
Goodwill i	92.1B	3.3B	3.4B
Intangible Assets i	15.5B	3.3B	3.4B
Long-term Investments	-	-	-
Other Non-Current Assets	470.9M	-	-
Total Non-Current Assets i	64.6B	11.3B	17.8B
Total Assets i	75.5B	13.1B	20.1B
Liabilities
Current Liabilities
Accounts Payable i	1.8B	810.2M	948.2M
Short-term Debt i	5.6B	2.9B	5.1B
Current Portion of Long-term Debt	-	-	-
Other Current Liabilities	2.5B	59.6M	59.6M
Total Current Liabilities i	11.1B	6.3B	8.7B
Non-Current Liabilities
Long-term Debt i	3.8B	2.8B	3.6B
Deferred Tax Liabilities i	1.6B	-	-
Other Non-Current Liabilities	11.9M	-	-
Total Non-Current Liabilities i	5.6B	2.8B	3.6B
Total Liabilities i	16.7B	9.1B	12.2B
Equity
Common Stock i	114.4M	40.1M	40.1M
Retained Earnings i	-	-18.2B	-14.3B
Treasury Stock i	-	-	-
Other Equity	-	-	-
Total Shareholders Equity i	58.8B	4.0B	7.9B
Key Metrics
Total Debt i	9.4B	5.7B	8.6B
Working Capital i	-273.8M	-4.5B	-6.4B

Balance Sheet Composition

OneSource Specialty Cash Flow Statement From 2023 to 2025

Metric	2025	2024	2023
Operating Activities
Net Income i	-677.6M	-3.9B	-8.0B
Depreciation & Amortization i	-	-	-
Stock-Based Compensation i	43.1M	19.6M	59.6M
Working Capital Changes i	-3.0B	119.6M	66.0M
Operating Cash Flow i	-2.2B	-3.3B	-6.7B
Investing Activities
Capital Expenditures i	-	-	-
Acquisitions i	0	-37.9M	0
Investment Purchases i	-905.6M	-394.2M	-268.7M
Investment Sales i	-	610.2M	-
Investing Cash Flow i	-861.6M	5.7B	-268.7M
Financing Activities
Share Repurchases i	-	-	-
Dividends Paid i	-	-	-
Debt Issuance i	2.5B	6.5B	528.5M
Debt Repayment i	-6.3B	-9.3B	-4.9B
Financing Cash Flow i	5.9B	-4.1B	2.3B
Free Cash Flow i	-2.0B	-1.7B	-2.1B
Net Change in Cash i	2.9B	-1.7B	-4.7B

Cash Flow Trend

OneSource Specialty Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1,155.58

Forward P/E 27.50

Price to Book 3.62

Price to Sales 14.39

Profitability Ratios

Profit Margin -0.85%

Operating Margin 6.32%

Return on Equity -0.31%

Return on Assets -0.24%

Financial Health

Debt to Equity 16.03

Per Share Data

EPS (TTM) ₹-1.12

Book Value per Share ₹514.02

Revenue per Share ₹139.20

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
onesource	213.0B	-1,155.58	3.62	-0.31%	-0.85%	16.03
Biocon	479.8B	112.34	1.99	3.66%	2.44%	66.26
Concord Biotech	184.9B	51.82	10.20	20.50%	29.97%	0.16
Blue Jet Healthcare	134.6B	37.48	11.87	26.93%	29.35%	1.76
Supriya Lifescience	55.5B	31.16	5.54	18.86%	26.16%	0.54
Dishman Carbogen	42.0B	40.32	0.72	0.06%	3.60%	40.97

Financial data is updated regularly. All figures are in the company's reporting currency.